UK Regulator Says Limit Trial Size to What Will Prove Safety, Efficacy

Devices & Diagnostics Letter
Medical devicemakers should avoid recruiting and putting at risk an unnecessarily large number of patients in clinical trials, the UK’s Medicines and Healthcare products Regulatory Agency says in one of five trial-related guidances issued last month.

To View This Article:


Buy This Article Now

Add this article to your cart for $25.00